Peter Radovich

Peter Radovich

President and Chief Operating OfficeratMirum Pharmaceuticals· In proxies 2022–2025

Pay in FY2025+19% from the year before · Mirum Pharmaceuticals stock +91.0% the same year

Peter Radovich was paid $4.0M in FY2025 (Dec), up 19%. Mirum Pharmaceuticals stock rose 91.0% that year.

Pay$100 in the stock at the end of FY21 → $495
Pay is from the Summary Compensation Table of each Mirum Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Mirum PharmaceuticalsPublic company · 4 yr
    • President and Chief Operating Officer2022 – Present · 4 yrStock in role +447%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?